Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 15, 2021

View Archived Issues

LPAR1 antagonist PIPE-791 promotes remyelination in multiple sclerosis

Jmackem divulges new TRPV1 antagonists

Heptares Therapeutics patents histamine H4 receptor antagonists

Tenova Pharmaceuticals discloses EGFR and/or ALK inhibitors

Janssen Pharmaceutica identifies NLRP3 inflammasome inhibitors

Assembly Biosciences synthesizes new HBV antivirals

M-6223 induces antitumor immune response through multiple mechanisms of action

First preclinical results of AB-201, a novel allogeneic anti-HER2 CAR NK-cell therapy

BACE1 inhibition may find new target in glioblastoma

PA-001 for COVID-19 completes preclinical testing

UCARTMESO, MSLN-targeting allogeneic CAR T cells with preclinical efficacy against solid tumors

Seno-7284 shows efficacy in preclinical models of age-related cardiometabolic disease

ADAR1 Z alpha-domain-mutated mice display Aicardi-Goutieres syndrome defects

EIF4 inhibitor pateamine A improves immunological and neurological functioning in murine lupus model

Targeting pathogenic activation of autophagy in a new LGMDD2 fly model rescues muscle phenotypes

Systems biology approaches unveil in vivo commensal control of Clostridioides difficile virulence

Juva adds second novel noncannabinoid compound to pipeline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.